0001675383-16-000001.txt : 20160603 0001675383-16-000001.hdr.sgml : 20160603 20160603115217 ACCESSION NUMBER: 0001675383-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 EFFECTIVENESS DATE: 20160603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spectrix Therapeutics, LLC CENTRAL INDEX KEY: 0001675383 IRS NUMBER: 812339107 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-264350 FILM NUMBER: 161694673 BUSINESS ADDRESS: STREET 1: 2535 EAST SOUTHLAKE BOULEVARD STREET 2: SUITE 200 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: 817-313-9539 MAIL ADDRESS: STREET 1: 2535 EAST SOUTHLAKE BOULEVARD STREET 2: SUITE 200 CITY: SOUTHLAKE STATE: TX ZIP: 76092 D 1 primary_doc.xml X0707 D LIVE 0001675383 Spectrix Therapeutics, LLC 2535 EAST SOUTHLAKE BOULEVARD SUITE 200 SOUTHLAKE TX TEXAS 76092 817-313-9539 DELAWARE None None Limited Liability Company true 2016 Mark Tengler 2535 East Southlake Boulevard Suite 200 Southlake TX TEXAS 76092 Executive Officer Chief Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-05-20 false true false 0 249000 249000 0 false 5 0 0 0 false Spectrix Therapeutics, LLC /s/ Mark Tengler Mark Tengler Chief Executive Officer 2016-06-03